Effect of Idebenone on Respiratory Function Across Various Subgroups in Patients with Duchenne Muscular Dystrophy (DMD)

被引：0
|
作者：
Karafilidis, J. [1 ]
Mayer, H. [2 ]
Rummey, C. [3 ]
Buyse, G. [4 ]
机构：
[1] Santhera Pharmaceut, Med Affairs, Burlington, MA USA
[2] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[3] Santhera Pharmaceut, Liestal, Switzerland
[4] Univ Hosp Leuven, Leuven, Belgium
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5865
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Respiratory function in eteplirsen-treated Duchenne muscular dystrophy (DMD) patients compared to natural history
    Kinane, B.
    Mayer, O.
    Lowes, L.
    Khan, N.
    Gallitano, K.
    Duda, P.
    Mendell, J.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S154 - S154
  • [22] AMBULATORY FUNCTION IN DUCHENNE MUSCULAR DYSTROPHY (DMD): THE CHARACTERISTIC TRAJECTORY AND VARIATION ACROSS INDIVIDUALS
    Signorovitch, J.
    Muntoni, F.
    Sajeev, G.
    Yao, Z.
    Ward, S. J.
    Abrams, K. R.
    VALUE IN HEALTH, 2018, 21 : S11 - S11
  • [23] Glucocorticoids influence therapeutic efficacy of idebenone (Catena®) on peak expiratory flow in patients with Duchenne muscular dystrophy (DMD)
    Buyse, G. M.
    Goemans, N.
    van den Hauwe, M.
    de Groot, I. J. M.
    Schara, U.
    Ceulemans, B.
    Meier, T.
    NEUROMUSCULAR DISORDERS, 2009, 19 (8-9) : 610 - 610
  • [24] Bone density in patients with Duchenne muscular dystrophy (DMD)
    Eagle, M
    Rawlings, D
    Straub, V
    Bushby, K
    NEUROMUSCULAR DISORDERS, 2005, 15 (9-10) : 689 - 689
  • [25] Effect of idebenone on bronchopulmonary adverse events and hospitalizations in patients with Duchene muscular dystrophy (DMD)
    Lawrence, C.
    Wamock, A.
    McDonald, C.
    Mayer, O.
    Meier, T.
    Leinonen, M.
    Buyse, G.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S16 - S17
  • [26] Effect Of Idebenone On Bronchopulmonary Adverse Events And Hospitalizations In Patients With Duchene Muscular Dystrophy (dmd)
    Mayer, O.
    McDonald, C.
    Meier, T.
    Leinonen, M.
    Buyse, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [27] Impact of idebenone on pulmonary morbidity, including bronchopulmonary adverse events, in Duchenne muscular dystrophy (DMD)
    Mayer, O.
    Rummey, C.
    Buyse, G.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S219 - S219
  • [28] Design of an international phase III study with idebenone (Catena®) in patients with Duchenne muscular dystrophy (DMD) - The DELOS study
    Buyse, G. M.
    Meier, T.
    Finkel, R. S.
    NEUROMUSCULAR DISORDERS, 2009, 19 (8-9) : 612 - 612
  • [29] Scoliosis in Duchenne muscular dystrophy (DMD)
    Hsu, John D.
    Quinlivan, Ros
    NEUROMUSCULAR DISORDERS, 2013, 23 (08) : 611 - 617
  • [30] Analysis of motor and respiratory function in Duchenne muscular dystrophy patients
    Luiz, Livia Cocato
    Lima Marson, Fernando Augusto
    Bresciani Almeida, Celize Cruz
    Dalbo Contrera Toro, Adyleia Aparecida
    Nucci, Anamarli
    Ribeiro, Jose Dirceu
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2019, 262 : 1 - 11
12345